HRT Financial’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-108,012
| Closed | -$2.62M | – | 2441 |
|
|
2025
Q1 | $2.62M | Buy |
+108,012
| New | +$2.62M | 0.02% | 577 |
|
|
2024
Q4 | – | Sell |
-105,743
| Closed | -$2.1M | – | 2315 |
|
|
2024
Q3 | $2.1M | Buy |
+105,743
| New | +$2.1M | 0.01% | 811 |
|
|
2024
Q1 | – | Sell |
-37,623
| Closed | -$632K | – | 2298 |
|
|
2023
Q4 | $632K | Sell |
37,623
-20,003
| -35% | -$336K | ﹤0.01% | 1146 |
|
|
2023
Q3 | $673K | Buy |
57,626
+41,747
| +263% | +$488K | 0.01% | 1105 |
|
|
2023
Q2 | $213K | Sell |
15,879
-206,299
| -93% | -$2.77M | ﹤0.01% | 1630 |
|
|
2023
Q1 | $3.68M | Buy |
222,178
+188,073
| +551% | +$3.12M | 0.04% | 329 |
|
|
2022
Q4 | $634K | Buy |
34,105
+888
| +3% | +$16.5K | 0.01% | 1171 |
|
|
2022
Q3 | $426K | Sell |
33,217
-154,902
| -82% | -$1.99M | ﹤0.01% | 1649 |
|
|
2022
Q2 | $1.32M | Buy |
+188,119
| New | +$1.32M | 0.01% | 753 |
|
|
2022
Q1 | – | Sell |
-132,366
| Closed | -$896K | – | 2930 |
|
|
2021
Q4 | $896K | Buy |
132,366
+98,986
| +297% | +$670K | 0.01% | 1083 |
|
|
2021
Q3 | $176K | Buy |
+33,380
| New | +$176K | ﹤0.01% | 2474 |
|
|
2021
Q1 | – | Sell |
-108,714
| Closed | -$363K | – | 2528 |
|
|
2020
Q4 | $363K | Buy |
+108,714
| New | +$363K | 0.01% | 1130 |
|
|
2020
Q3 | – | Sell |
-49,888
| Closed | -$230K | – | 1862 |
|
|
2020
Q2 | $230K | Buy |
+49,888
| New | +$230K | 0.01% | 976 |
|